Abstract:Bovine respiratory disease (BRD) remains a leading cause of economic losses, hampered animal welfare and antimicrobial use. The use of acute phase proteins (APPs), such as serum amyloid A (SAA) and haptoglobin (Hp), has been explored for the detection of BRD, as defined by clinical signs. However, whether these APPs are also associated with lung consolidation, as determined by thoracic ultrasonography, and have the potential to differentiate causative pathogens is unknown. Therefore, the primary objective of this study was to explore the association between lung consolidation and SAA and Hp. The second objective was to determine the ability of both SAA and Hp to differentiate pathogen groups (Mycoplasmopsis bovis, viruses and Pasteurellaceae). A cross-sectional study including 170 calves from 25 different herds with a history of Mycoplasmopsis bovis (M. bovis) (endemic, n = 94, 9 herds) or herds (including M. bovis positive herds) that met the inclusion criteria of an outbreak of BRD (i.e., the presence of one or more clinical signs associated with BRD, affecting multiple animals (5 animals; 15% ill animals in the same airspace on a farm within a 48-h period) (epidemic, n = 76, 16 herds) was conducted between 2020 and 2022 in Belgium. Clinical examination, quick thoracic ultrasonography (qTUS), blood sampling and non-endoscopic bronchoalveolar lavage (nBAL) were performed on each calf. Linear mixed effect models with a random intercept for herd were fitted, to determine the association between lung consolidations (depth ≥ 1 cm or ≥3cm) or clinical BRD (UC Davis BRD scorecard positive) and serum SAA and Hp concentrations. Furthermore, multivariable models (linear mixed effect models) were used to evaluate the mutually adjusted associations between pathogen groups and APP concentrations. Test characteristics of APP concentrations to predict the presence of lung consolidation or pathogen groups were assessed, and potential SAA and Hp cutoffs, determined by Youden index, were evaluated. Lung consolidation (≥1 cm) was positively association with higher Hp concentrations in epidemic conditions [regression coefficient (β): 5.3 (95% confidence interval (CI): 1.4-20.3)], while more severe lung consolidation (≥3 cm) was associated with higher Hp concentrations in endemic conditions [β: 3.6 (95% CI: 1.2-11.0)]. No positive association was found between lung consolidation and SAA. Yet, a positive association between M. bovis and SAA was observed [β: 2.3 (95% CI: 1.3-4.3)]. At last, no association was found between M. Bovis and Hp. For Hp, the best cutoff to predict a lung consolidation (≥1 cm) was 2.33 µg/mL (Se: 81.8% and Sp: 66.7%). Moreover, to detect M. bovis among calves with a lung consolidation (≥1 cm), a SAA cutoff of 174.84 µg/mL was determined (Se: 77.8% and Sp: 87.5%). Despite the observed relationships between lung consolidation, pathogen groups, and APPs, the test characteristics in this study suggest that Hp and SAA are currently limited in their (practical) use for the detection of lung consolidation or M. bovis.

Comparison of C‐reactive protein concentrations in dogs with Bordetella bronchiseptica infection and aspiration bronchopneumonia

Bacterial infection in dogs with aspiration pneumonia at 2 tertiary referral practices

Comparison of lung ultrasound, chest radiographs, C‐reactive protein, and clinical findings in dogs treated for aspiration pneumonia

Serial evaluation of thoracic radiographs and acute phase proteins in dogs with pneumonia

Measurement and clinical applications of C‐reactive protein in gastrointestinal diseases of dogs

Clinical and bacteriological analysis of respiratory tract infections in sheltered dogs and determination of antibacterial treatment options

Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD

Usefulness of C-reactive protein and serum amyloid A in early detection of postoperative infectious complications to tibial plateau leveling osteotomy in dogs

Diagnostic Utility of Canine C-Reactive Protein, Haptoglobin, and 25-Hydroxyvitamin-D in Dogs with Nasal Cavity Disease

Comparison of bacterial culture results obtained from three different sampling locations in dogs and cats with chronic nasal disease

Cardiac biomarker profiles in dogs with naturally occurring precapillary pulmonary hypertension

Serial analysis of blood biomarker concentrations in dogs with pneumonia, septic peritonitis, and pyometra

Antibody response over time correlated with treatment outcome in 30 dogs naturally infected with Brucella canis (2017-2022)

Association between lung consolidation and serum amyloid-A and haptoglobin, and the potential of acute phase proteins to differentiate primary respiratory tract pathogens in calves

Acute phase response in bronchiectasis and bronchus carcinoma

Bacterial DNA and serum IgG antibody titer assays for assessing infection of human-pathogenic and dog-pathogenic Porphyromonas species in dogs

Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies

Circulating markers of endothelial activation in canine parvoviral enteritis

Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome

Systematic Review of the Diagnostic Accuracy of Haptoglobin, Serum Amyloid A, and Fibrinogen versus Clinical Reference Standards for the Diagnosis of Bovine Respiratory Disease

Asymptomatic carriage of canine infectious respiratory disease complex pathogens among healthy dogs